These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

91 related articles for article (PubMed ID: 24664538)

  • 1. Copy number alterations and neoplasia-specific mutations in MELK, PDCD1LG2, TLN1, and PAX5 at 9p in different neoplasias.
    Sarhadi VK; Lahti L; Scheinin I; Ellonen P; Kettunen E; Serra M; Scotlandi K; Picci P; Knuutila S
    Genes Chromosomes Cancer; 2014 Jul; 53(7):579-88. PubMed ID: 24664538
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Variable breakpoints target PAX5 in patients with dicentric chromosomes: a model for the basis of unbalanced translocations in cancer.
    An Q; Wright SL; Konn ZJ; Matheson E; Minto L; Moorman AV; Parker H; Griffiths M; Ross FM; Davies T; Hall AG; Harrison CJ; Irving JA; Strefford JC
    Proc Natl Acad Sci U S A; 2008 Nov; 105(44):17050-4. PubMed ID: 18957548
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Targeted resequencing of 9p in acute lymphoblastic leukemia yields concordant results with array CGH and reveals novel genomic alterations.
    Sarhadi VK; Lahti L; Scheinin I; Tyybäkinoja A; Savola S; Usvasalo A; Räty R; Elonen E; Ellonen P; Saarinen-Pihkala UM; Knuutila S
    Genomics; 2013 Sep; 102(3):182-8. PubMed ID: 23333812
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Deletions and rearrangements of PAX5 gene in B-lineage acute lymphoblastic leukemia].
    Zheng JF; Dong SS; Wang Q; Pan JL; Chen SN; Qiu HY
    Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 2013 Oct; 30(5):549-52. PubMed ID: 24078568
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Wide diversity of PAX5 alterations in B-ALL: a Groupe Francophone de Cytogenetique Hematologique study.
    Coyaud E; Struski S; Prade N; Familiades J; Eichner R; Quelen C; Bousquet M; Mugneret F; Talmant P; Pages MP; Lefebvre C; Penther D; Lippert E; Nadal N; Taviaux S; Poppe B; Luquet I; Baranger L; Eclache V; Radford I; Barin C; Mozziconacci MJ; Lafage-Pochitaloff M; Antoine-Poirel H; Charrin C; Perot C; Terre C; Brousset P; Dastugue N; Broccardo C
    Blood; 2010 Apr; 115(15):3089-97. PubMed ID: 20160164
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Chromosome 9p copy number gains involving PD-L1 are associated with a specific proliferation and immune-modulating gene expression program active across major cancer types.
    Budczies J; Denkert C; Győrffy B; Schirmacher P; Stenzinger A
    BMC Med Genomics; 2017 Dec; 10(1):74. PubMed ID: 29212506
    [TBL] [Abstract][Full Text] [Related]  

  • 7. PAX5 biallelic genomic alterations define a novel subgroup of B-cell precursor acute lymphoblastic leukemia.
    Bastian L; Schroeder MP; Eckert C; Schlee C; Tanchez JO; Kämpf S; Wagner DL; Schulze V; Isaakidis K; Lázaro-Navarro J; Hänzelmann S; James AR; Ekici A; Burmeister T; Schwartz S; Schrappe M; Horstmann M; Vosberg S; Krebs S; Blum H; Hecht J; Greif PA; Rieger MA; Brüggemann M; Gökbuget N; Neumann M; Baldus CD
    Leukemia; 2019 Aug; 33(8):1895-1909. PubMed ID: 30842609
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Focal 9p instability in hematologic neoplasias revealed by comparative genomic hybridization and single-nucleotide polymorphism microarray analyses.
    Usvasalo A; Ninomiya S; Räty R; Hollmén J; Saarinen-Pihkala UM; Elonen E; Knuutila S
    Genes Chromosomes Cancer; 2010 Apr; 49(4):309-18. PubMed ID: 20013897
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A recurrent germline PAX5 mutation confers susceptibility to pre-B cell acute lymphoblastic leukemia.
    Shah S; Schrader KA; Waanders E; Timms AE; Vijai J; Miething C; Wechsler J; Yang J; Hayes J; Klein RJ; Zhang J; Wei L; Wu G; Rusch M; Nagahawatte P; Ma J; Chen SC; Song G; Cheng J; Meyers P; Bhojwani D; Jhanwar S; Maslak P; Fleisher M; Littman J; Offit L; Rau-Murthy R; Fleischut MH; Corines M; Murali R; Gao X; Manschreck C; Kitzing T; Murty VV; Raimondi S; Kuiper RP; Simons A; Schiffman JD; Onel K; Plon SE; Wheeler D; Ritter D; Ziegler DS; Tucker K; Sutton R; Chenevix-Trench G; Li J; Huntsman DG; Hansford S; Senz J; Walsh T; Lee M; Hahn CN; Roberts K; King MC; Lo SM; Levine RL; Viale A; Socci ND; Nathanson KL; Scott HS; Daly M; Lipkin SM; Lowe SW; Downing JR; Altshuler D; Sandlund JT; Horwitz MS; Mullighan CG; Offit K
    Nat Genet; 2013 Oct; 45(10):1226-1231. PubMed ID: 24013638
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Evaluation of multiplex ligation-dependent probe amplification as a method for the detection of copy number abnormalities in B-cell precursor acute lymphoblastic leukemia.
    Schwab CJ; Jones LR; Morrison H; Ryan SL; Yigittop H; Schouten JP; Harrison CJ
    Genes Chromosomes Cancer; 2010 Dec; 49(12):1104-13. PubMed ID: 20815030
    [TBL] [Abstract][Full Text] [Related]  

  • 11. PAX5 mutations occur frequently in adult B-cell progenitor acute lymphoblastic leukemia and PAX5 haploinsufficiency is associated with BCR-ABL1 and TCF3-PBX1 fusion genes: a GRAALL study.
    Familiades J; Bousquet M; Lafage-Pochitaloff M; Béné MC; Beldjord K; De Vos J; Dastugue N; Coyaud E; Struski S; Quelen C; Prade-Houdellier N; Dobbelstein S; Cayuela JM; Soulier J; Grardel N; Preudhomme C; Cavé H; Blanchet O; Lhéritier V; Delannoy A; Chalandon Y; Ifrah N; Pigneux A; Brousset P; Macintyre EA; Huguet F; Dombret H; Broccardo C; Delabesse E
    Leukemia; 2009 Nov; 23(11):1989-98. PubMed ID: 19587702
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Detection of CDKN2 deletions in tumor cell lines and primary glioma by interphase fluorescence in situ hybridization.
    Dreyling MH; Bohlander SK; Adeyanju MO; Olopade OI
    Cancer Res; 1995 Mar; 55(5):984-8. PubMed ID: 7867008
    [TBL] [Abstract][Full Text] [Related]  

  • 13. CGH analysis shows genetic similarities and differences in atypical fibroxanthoma and undifferentiated high grade pleomorphic sarcoma.
    Mihic-Probst D; Zhao J; Saremaslani P; Baer A; Oehlschlegel C; Paredes B; Komminoth P; Heitz PU
    Anticancer Res; 2004; 24(1):19-26. PubMed ID: 15015571
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Mutation and expression of PAX5 gene in adult acute lymphoblastic leukemia].
    Lin ZK; Zhang R; Ge Z; Xu JY; Liu J; Guo X; Li M; Wu YJ; Qiao C; Qiu HR; Zhang JF; Li JY
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2014 Oct; 22(5):1206-11. PubMed ID: 25338558
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Evidence for two tumor suppressor loci associated with proximal chromosome 9p to q and distal chromosome 9q in bladder cancer and the initial screening for GAS1 and PTC mutations.
    Simoneau AR; Spruck CH; Gonzalez-Zulueta M; Gonzalgo ML; Chan MF; Tsai YC; Dean M; Steven K; Horn T; Jones PA
    Cancer Res; 1996 Nov; 56(21):5039-43. PubMed ID: 8895761
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Genome-wide association analysis identifies genetic correlates of immune infiltrates in solid tumors.
    Siemers NO; Holloway JL; Chang H; Chasalow SD; Ross-MacDonald PB; Voliva CF; Szustakowski JD
    PLoS One; 2017; 12(7):e0179726. PubMed ID: 28749946
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Identification of chromosome arm 9p as the most frequent target of homozygous deletions in lung cancer.
    Sato M; Takahashi K; Nagayama K; Arai Y; Ito N; Okada M; Minna JD; Yokota J; Kohno T
    Genes Chromosomes Cancer; 2005 Dec; 44(4):405-14. PubMed ID: 16114034
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Locus-specific ChIP combined with NGS analysis reveals genomic regulatory regions that physically interact with the Pax5 promoter in a chicken B cell line.
    Fujita T; Kitaura F; Yuno M; Suzuki Y; Sugano S; Fujii H
    DNA Res; 2017 Oct; 24(5):537-548. PubMed ID: 28586432
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Identification of a novel region of homozygous deletion on chromosome 9p in squamous cell carcinoma of the lung: the location of a putative tumor suppressor gene.
    Wiest JS; Franklin WA; Otstot JT; Forbey K; Varella-Garcia M; Rao K; Drabkin H; Gemmill R; Ahrent S; Sidransky D; Saccomanno G; Fountain JW; Anderson MW
    Cancer Res; 1997 Jan; 57(1):1-6. PubMed ID: 8988029
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Fine-mapping loss of gene architecture at the CDKN2B (p15INK4b), CDKN2A (p14ARF, p16INK4a), and MTAP genes in head and neck squamous cell carcinoma.
    Worsham MJ; Chen KM; Tiwari N; Pals G; Schouten JP; Sethi S; Benninger MS
    Arch Otolaryngol Head Neck Surg; 2006 Apr; 132(4):409-15. PubMed ID: 16618910
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.